The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Health
·
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
CN
CitrixNews Staff
Originally reported by New York Times
Related Articles
Health
What to know about the hantavirus outbreak on transatlantic cruise
Health What to know about the hantavirus outbreak on transatlantic cruise May 6, 20264:44 AM ET Heard on Morning Edit...
CitrixNews Staff
·
27 minutes ago
Health
Mums' choir leader 'baffled' by park fee structure
Mums' choir leader 'baffled' by park fee structure36 minutes agoShareSaveAdd as preferred on GoogleDawn L...
CitrixNews Staff
·
3 hours ago
Health
Cruise ship with hantavirus outbreak to sail to Canary Islands
Cruise ship with hantavirus outbreak to sail to Canary Islands16 minutes agoShareSaveAdd as preferred on GoogleKatherine...
CitrixNews Staff
·
11 hours ago
Health
Cruise ship with hantavirus may have seen a rare occurrence: humans infecting humans
Global Health Cruise ship with hantavirus may have seen a rare occurrence: humans infecting humans May 5, 20265:08 PM...
CitrixNews Staff
·
12 hours ago